Ignyta (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Biochemistry, Genetics and Molecular Biology 5.6×
• Social Sciences 2.5×
• Medicine 2.0×

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Clinical Trials, Chemotherapy, Immunotherapy, Genomic Profiling, ALK Inhibitors, EGFR Mutations and Prognostic Factors.

By volume in 2022–2025: Cutaneous Melanoma Detection and Management, PI3K/AKT/mTOR signaling in cancer, Cybersecurity and Cyber Warfare Studies and Cancer therapeutics and mechanisms.

1. 1 Cutaneous Melanoma Detection and Management Oncology 0 works
2. 2 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
3. 3 Cybersecurity and Cyber Warfare Studies Political Science and International Relations 0 works
4. 4 Cancer therapeutics and mechanisms Molecular Biology 0 works
5. 5 CAR-T cell therapy research Oncology 0 works
6. 6 Melanoma and MAPK Pathways Molecular Biology 0 works
7. 7 Security, Politics, and Digital Transformation Political Science and International Relations 0 works
8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
9. 9 European and Russian Geopolitical Military Strategies Political Science and International Relations 0 works
10. 10 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 71% lower than in 2013–2017.

• University of California San Diego
• San Diego State University
• Scripps Research Institute
• University of San Diego
• University of California San Diego Medical Center
• General Atomics (United States)
• Scripps Health
• Naval Medical Center San Diego